Fertility clinic M&A demands specialized expertise in physician MSO structures, SART compliance, and private equity recapitalization. The wrong broker costs you millions.
Find Fertility Clinic Deals Without a BrokerFertility clinics trade at 5–9x EBITDA with strategic PE buyers like US Fertility and CCRM driving premium valuations. SBA financing is not available; deals require specialized advisors fluent in corporate practice of medicine laws, CLIA accreditation, and physician rollover equity structures.
Boutique investment banks focusing on physician practice transactions with direct relationships to PE-backed fertility platforms and regional health systems pursuing ART service line acquisitions.
Best for: Fertility clinics with $1.5M+ EBITDA seeking competitive auction processes with multiple PE or strategic bidders.
Advisors with deep knowledge of corporate practice of medicine doctrine, MSO legal structures, and physician employment agreements who guide founders through compliant, financially optimized exits.
Best for: Retiring reproductive endocrinologists needing legal structuring, QoE preparation, and buyer vetting before engaging a full investment bank.
General healthcare brokers with local market relationships covering smaller fertility practices or single-physician clinics that fall below PE acquisition thresholds but attract entrepreneurial physician buyers.
Best for: Single-RE fertility practices under $1M EBITDA seeking physician-to-physician transitions or regional group practice acquisitions.
Skip the broker — find deals direct
DealFlow OS surfaces off-market Fertility Clinic targets with seller signals and outreach angles. No commission.
How many fertility or ART practice transactions have you closed in the last three years, and what were the EBITDA multiples achieved?
Generic healthcare brokers undervalue fertility clinics by misunderstanding SART data, MSO structures, and PE buyer appetite for IVF platform acquisitions.
Do you have existing relationships with PE-backed fertility networks such as US Fertility, CCRM, or Inception Fertility?
Warm buyer relationships accelerate timelines and create competitive tension that drives valuation multiples toward the 7–9x range versus 5–6x cold outreach results.
How do you handle physician transition risk and structure earnouts tied to patient retention after the founding RE departs?
Buyer concern over single-physician dependency is the top deal killer; your broker must proactively structure employment agreements and earnouts to neutralize this risk.
Can you coordinate with our healthcare attorney on corporate practice of medicine compliance and the MSO structure before we go to market?
Non-compliant legal structures discovered during due diligence collapse deals; brokers who cannot navigate MSO documentation are a liability, not an asset.
No. Fertility clinics are not SBA-eligible due to passive income and healthcare licensing restrictions. Acquisitions rely on PE equity, seller financing, or conventional bank debt with physician guarantees.
Fertility clinics with $1.5M+ EBITDA, SART membership, and multiple REs typically sell at 6–9x EBITDA. Single-physician clinics with below-average success rates trade closer to 4–5x.
Expect 18–24 months from pre-marketing preparation through closing. Regulatory due diligence on CLIA accreditation, SART data, and physician agreements extends timelines compared to non-healthcare deals.
An MSO separates clinical operations, owned by a licensed physician entity, from business management, owned by the acquirer. It satisfies corporate practice of medicine laws while allowing PE buyers to control economics.
More Fertility Clinic Guides
Find Brokers in Other Industries
DealFlow OS surfaces off-market targets, scores seller motivation, and writes your outreach. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers